<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01012648</url>
  </required_header>
  <id_info>
    <org_study_id>BURN</org_study_id>
    <nct_id>NCT01012648</nct_id>
  </id_info>
  <brief_title>Early Fluid Resuscitation With Balanced HES 130/0.4 [6%] in Severe Burn Injury</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <brief_summary>
    <textblock>
      RCT colloids versus cristalloids only in severe burn victims.

        -  Trial with medicinal product
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">January 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduced amount of fluids given</measure>
    <time_frame>3 days</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Burns</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluid resuscitation</intervention_name>
    <description>Volume resuscitation</description>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HES 130/0.4 (6%), Voluven balanced vs. Lactated Ringer's solution</intervention_name>
    <description>Volume Resuscitation</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Deep burn injury more than 15% of total body surface area (2nd and 3rd degree burns)

          -  Informed consent (via deferred consent, if necessary, according to Swiss HMG § 55 and
             56).

          -  Patients or relatives can understand the study information and the provided
             information in German language

        Exclusion criteria:

          -  Patients expected to succumb within the next 24 to 36 hours, i.e. whole body burn
             trauma, palliative care situation

          -  Pregnancy

          -  No informed consent

          -  Known allergic reaction to HES

          -  Patients or patient's relatives, who do not understand the German language and
             therefore the study information, can not be provided in a legally correct manner.

          -  Patients with contraindications for balanced 6% HES 130/0.4, i.e. heart failure,
             pulmonary edema, intracerebral bleeding, acute renal failure, severe hypernatraemia
             and other severe electrolyte imbalances, severe von-Willebrand Syndrome and acute
             liver failure (see &quot;Arzneimittelkompendium der Schweiz® - Documed&quot;)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Markus Béchir, M.D:</last_name>
    <role>Principal Investigator</role>
    <affiliation>UniversitaetsSpital Zuerich</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>01 Studienregister MasterAdmins</last_name>
    <phone>+41 (0)44 255 11 11</phone>
  </overall_contact>
  <location>
    <facility>
      <name>Surgical ICU</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Béchir, M.D.</last_name>
    </contact>
    <investigator>
      <last_name>Markus Béchir, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>March 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 29, 2009</study_first_submitted>
  <study_first_submitted_qc>November 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 13, 2009</study_first_posted>
  <last_update_submitted>March 15, 2011</last_update_submitted>
  <last_update_submitted_qc>March 15, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 16, 2011</last_update_posted>
  <responsible_party>
    <name_title>Béchir Markus, MD</name_title>
    <organization>Intensivmedizin</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

